Sale!

PDL1 SP263 Clone Test Cost

Original price was: 3,200 د.إ.Current price is: 2,400 د.إ.

-25%

The PDL1 SP263 Clone Test is a diagnostic assay performed at DNA Labs UAE, designed to evaluate the expression of the Programmed Death-Ligand 1 (PD-L1) protein in cancer patients. PD-L1 is a crucial protein involved in the body’s immune response to cancer, as it can suppress the immune system and allow cancer cells to grow and spread. The SP263 clone is a specific antibody used in immunohistochemistry (IHC) to detect PD-L1 expression in tumor cells and immune cells within the tumor microenvironment.

This test is particularly important for patients with certain types of cancer, such as non-small cell lung cancer (NSCLC), urothelial carcinoma, and others, as it helps in determining their eligibility for immunotherapy treatments targeting PD-L1. By identifying patients who express PD-L1, clinicians can tailor treatment plans to include therapies that block the PD-L1 pathway, potentially leading to better treatment outcomes.

The cost of the PDL1 SP263 Clone Test at DNA Labs UAE is 2400 AED. This investment in diagnostics is vital for enabling personalized medicine, allowing for treatments that are more specifically aligned with the individual’s cancer characteristics. The test is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers in making informed treatment decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PDL1 SP263 Clone Test

Welcome to DNA Labs UAE, a leading genetic laboratory offering the PDL1 SP263 Clone Test for detecting the expression of programmed death-ligand 1 (PDL1) in tumor tissues.

Test Name: PDL1 SP263 Clone Test

Components: Properly packed and previously labeled slides and blocks with clinical details and proper requisition form

Price: 2400.0 AED

Sample Condition: Blocks

Report Delivery: 6 days

Method: IHC (Immunohistochemistry)

Test Type: Genetics

Doctor: Oncology

Test Department:

Pre Test Information

The PDL1 SP263 Clone Test requires a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The PDL1 SP263 Clone Test utilizes a monoclonal antibody called SP263 Clone in immunohistochemistry (IHC) testing. This antibody is used to detect the expression of PDL1 protein in tumor tissues. PDL1 is a protein found on the surface of cancer cells and is responsible for suppressing the immune system’s response to cancer.

The SP263 Clone specifically binds to the PDL1 protein, allowing pathologists to assess the level of PDL1 expression in tumor cells. This information is crucial in determining the potential response of a patient to immunotherapy drugs that target the PD-1/PDL1 pathway.

The SP263 Clone has been validated and approved for use in various cancer types, including non-small cell lung cancer, urothelial carcinoma, and head and neck squamous cell carcinoma. It provides reliable and reproducible results, aiding in the decision-making process for personalized cancer treatment.

Test Name PDL1 SP263 Clone Test
Components Properly packed and previosly labelled slides and blocks with clinical details and proper requisition form
Price 2400.0 AED
Sample Condition Blocks
Report Delivery 6 days
Method IHC
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information PDL1 Ventana Roche SP263 Clone] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The PDL1 [SP263 Clone] is a monoclonal antibody used in immunohistochemistry (IHC) testing to detect the expression of programmed death-ligand 1 (PDL1) in tumor tissues. PDL1 is a protein found on the surface of cancer cells that plays a role in suppressing the immune system’s response to cancer.

The SP263 Clone is one of the commercially available clones used for PDL1 IHC testing. It specifically binds to the PDL1 protein, allowing pathologists to assess the level of PDL1 expression in tumor cells. This information is crucial in determining the potential response of a patient to immunotherapy drugs that target the PD-1/PDL1 pathway.

The SP263 Clone has been validated and approved for use in various cancer types, including non-small cell lung cancer, urothelial carcinoma, and head and neck squamous cell carcinoma. It provides reliable and reproducible results, aiding in the decision-making process for personalized cancer treatment.